Single-cell epigenomic identification of inherited risk loci in Alzheimer's and Parkinson's disease
M. Ryan CorcesiD, Anna ShcherbinaiD, Soumya KunduiD, Michael J. GloudemansiD, Laure FrésardiD, Jeffrey M. GranjaiD, Bryan H. LouieiD, Tiffany Y. EulalioiD, Shadi ShamsiD, S. Tansu BagdatliiD, Maxwell R. MumbachiD, Boxiang LiuiD, Kathleen S. MontineiD, William James GreenleafiD, Anshul Bharat KundajeiD, Stephen B. MontgomeryiD, Howard Y. ChangiD, Thomas Jude MontineiD
Abstract
Genome-wide association studies (GWAS) have identified thousands of variants associated with disease phenotypes. However, the majority of these variants do not alter coding sequences, making it difficult to assign their function. To this end, we present a multi-omic epigenetic atlas of the adult human brain through profiling of the chromatin accessibility landscapes and three-dimensional chromatin interactions of seven brain regions across a cohort of 39 cognitively healthy individuals. Single-cell chromatin accessibility profiling of 70,631 cells from six of these brain regions identifies 24 distinct cell clusters and 359,022 cell type-specific regulatory elements, capturing the regulatory diversity of the adult brain. We develop a machine learning classifier to integrate this multi-omic framework and predict dozens of functional single nucleotide polymorphisms (SNPs), nominating gene and cellular targets for previously orphaned GWAS loci. These predictions both inform well-studied disease-relevant genes, such as BIN1 in microglia for Alzheimers disease (AD) and reveal novel gene-disease associations, such as STAB1 in microglia and MAL in oligodendrocytes for Parkinsons disease (PD). Moreover, we dissect the complex inverted haplotype of the MAPT (encoding tau) PD risk locus, identifying ectopic enhancer-gene contacts in neurons that increase MAPT expression and may mediate this disease association. This work greatly expands our understanding of inherited variation in AD and PD and provides a roadmap for the epigenomic dissection of noncoding regulatory variation in disease.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 356
- FWCI
- 28.68
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Machine Learning-Based Prediction of Cell-type Resolved Brain eQTLs Enhances Discovery of Variants Explaining Alzheimer's Disease Heritability
Chirag M. Lakhani, Giacomo Cavalca, … David A. Knowles·medRxiv·Dec 4, 2025
- Genome-wide QTL mapping across three tissues highlights several Alzheimer's and Parkinson's disease loci potentially acting via DNA methylation
Olena Ohlei, Yasmine Sommerer, … Lars Bertram·medRxiv·Dec 22, 2023
- Modeling cis-regulatory variation in human brain enhancers across a large Parkinson's Disease cohort
Olga M. Sigalova, Alexandra Pančíková, … Stein Aerts·bioRxiv·Apr 16, 2026
- Cell type-specific enhancer-promoter connectivity maps in the human brain and disease risk association
Alexi Nott, Inge R. Holtman, … Christopher K. Glass·bioRxiv·Sep 22, 2019
- Integration of Alzheimer’s disease genetics and myeloid genomics reveals novel disease risk mechanisms
Gloriia Novikova, Edoardo M. Marcora, … Alison Goate·Alzheimer s & DementiaPeer-reviewed·Dec 1, 2020
- Integration of cell-specific gene expression and chromatin accessibility facilitates localization of neurodegenerative risk in microglia
Xylena Reed, Dominic J. Acri, … Mark Cookson·bioRxiv·Sep 17, 2026